Jean Quancard

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 5

Top Topics

Molecular Dynamics Simulations

Top Venues

Nature chemical biology

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Jean Quancard, Anna Vulpetti, Anders Bach, Brian Cox, Stéphanie M Guéret, Ingo V Hartung, Hannes F Koolman, Stefan A Laufer, Josef Messinger, Gianluca Sbardella, Russell Craft
The European Federation for Medicinal Chemistry and Chemical Biology (EFMC) Best Practice Initiative: Hit Generation. ChemMedChem (2023)
Jean Quancard, Anders Bach, Brian Cox, Russell Craft, Dirk Finsinger, Stéphanie M Guéret, Ingo V Hartung, Stefan A Laufer, Josef Messinger, Gianluca Sbardella, Hannes F Koolman
The European Federation for Medicinal Chemistry and Chemical Biology (EFMC) Best Practice Initiative: Phenotypic Drug Discovery. ChemMedChem 16 (11) (2021)
Jean Quancard, Oliver Simic, Carole Pissot Soldermann, Reiner Aichholz, Markus Blatter, Martin Renatus, Paulus Erbel, Samu Melkko, Ralf Endres, Mickael Sorge, Laurence Kieffer, Trixie Wagner, Karen Beltz, Paul Mcsheehy, Markus Wartmann, Catherine H Régnier, Thomas Calzascia, Thomas Radimerski, Marc Bigaud, Andreas Weiss, Frédéric Bornancin, Achim Schlapbach
Optimization of the In Vivo Potency of Pyrazolopyrimidine MALT1 Protease Inhibitors by Reducing Metabolism and Increasing Potency in Whole Blood. Journal of medicinal chemistry 63 (23) (2020)
Jean Quancard, Brian Cox, Dirk Finsinger, Stéphanie M Guéret, Ingo V Hartung, Hannes F Koolman, Josef Messinger, Gianluca Sbardella, Stefan A Laufer
The European Federation for Medicinal Chemistry (EFMC) Best Practice Initiative: Validating Chemical Probes. ChemMedChem 15 (24) (2020)
Jean Quancard, Theo Klein, Shan-Yu Fung, Martin Renatus, Nicola Hughes, Laura Israël, John J Priatel, Sohyeong Kang, Michael A Blank, Rosa I Viner, Jutta Blank, Achim Schlapbach, Paul Erbel, Jayachandran N Kizhakkedathu, Frédéric Villard, René Hersperger, Suzanne C Tough, Joerg Eder, Frédéric Bornancin, Christopher M Overall
An allosteric MALT1 inhibitor is a molecular corrector rescuing function in an immunodeficient patient. Nature chemical biology 15 (3) (2019)